This webinar will cover the following learning objectives:
- Outline the role of buprenorphine depots in the treatment of opioid dependence
- Compare the pharmacokinetic profiles, evidence for use, adverse effects, and patient experiences of buprenorphine depot formulations
- Identify key considerations for buprenorphine depot use and management in a hospital setting and special patient populations
- Describe the process and dosing considerations of transferring a patient from sublingual to depot buprenorphine
- Overview studies examining buprenorphine depots, including the DEBUT and UNLOC-T studies
- Review case examples of buprenorphine depot use in practice